[1] Arerican Diabetes Association and American Academy of Neu-rology. Consensus statement: Report and recommendations ofthe San Antonio conference on diabetic neuropathy[J]. DiabetesCare, 1988;11:592-597.
[2] 蒋雨平,陆费汉倩,郑白蒂,等,糖尿病性多发性周围神经病的WHOFNIF诊断标准和10年随访[J].上海医科大学学报,1993;20(S):9-14.
[3] American Diabetes Association, Standards of medical care in di-abetes[J]. Diabetes Care, 2007;30;S4-S41.
[4] Meltzer S, Leiter L, Daneman D, et al. 1998 Clinical practiceguidelines for the management of diabetes in Canada[J].CMAJ, 1998;159;S1-S29.
[5] Dyck PI, Karmnes JL, Daube J. Clirnical and neuropathologicalcriteria for the diagnosis and staging of diabetic polyneuropathy[J]. Brain, 1985; 108:861-880.
[6] Dyck PJ, Davies JL, Litchy WJ, et al.Longitudinal assessment of diabetic polyneuropathy using a composite score in the Roch-ester Diabetie Neuropathy Study cohort[J]. Neurology, 1997;49:229-239.
[7] 汤晓芙, 主编.神经系统临床电生理学(下)[M].第一版.北京:人民军医出版社,2002:227-228.
[8] 侯瑞芳,汤正义,宁光.痛性糖尿病周围神经病变的止痛药物治疗[J].世界临床药物,2006;27:154-157.
[9] 王维治, 主编.神经病学[M].第一版.北京:人民卫生出版社,2006:394-395.
[10] Sun Y, Lai MS, Lu CI. Efctiveness of vitanin B12 on diabetic neuropathy; systematic review of clinical controlled trials[J].Acls Naural Taincun 2005. 14.48-54.
[11] Laudadio C, Sima AA. Progression rates of diabetic neuropathy in placebo patients in an 18-month clinical trial[J]. J Diab Comp, 1998;12:121-127.
[12] Hotta N, Sakamoto N, Shigeta Y, et al. Clinical investigationof epalrestat, an aldose reductase inhibitor, on diabeticneurop-athy in japan: multicenter study[J]. J Diab Comp, 1996; l0:168-172.
[13] Airey M, Bennett C, Nicolucci A, et al. Aldose reductasein-hibitors for the prevention and treatment of diabetic peripheral neuropathy [J]. Cochrane Database Syst Rev, 2000; 1:CD002182.
[14] Chalk c, Benstead TJ, Moore F. Aldose reductase inhibitorsfor the treatment of diabetic polyneuropathy[J]. Cochrane Database Syst Rev, 2007;1:CD004572.
[15] 侯瑞芳,汤正义,宁光,糖尿病周围神经病变的检查方法及其诊断效率[J].国际内分泌代谢杂志,2006; 26: 270-272.
[16] Meijer JW, Bosma E, Lefrandt JD,et al. Clinical diagnosis ofdiabetic polyneuropathly with the diabetic neuropathy symptom and diabetic neuropathy examination scores[J]. Diabetes Care,2003;26:697-701.
[17] Boulton AJ, Vinik AI, Arezzo JC,et al. Diabetic neuropa-thies: a statement by the American Diabetes Association [J].Diabetes Care, 2005; 28:956-962. |
